WS
CPAH

Wedbush Securities’s Counterpath Corp CPAH Stock Holding History

Wedbush Securities’s Portfolio CPAH Stock Details CPAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18,931
Closed -$38K – 1036
2020
Q1 		$38K Sell
18,931
-39,785
-68% -$89.7K ﹤0.01% 840
2019
Q4 		$55K Buy
58,716
+30,524
+108% +$33.1K ﹤0.01% 961
2019
Q3 		$32K Buy
28,192
+11,874
+73% +$15.7K ﹤0.01% 961
2019
Q2 		$25K Sell
16,318
-9,682
-37% -$16K ﹤0.01% 971
2019
Q1 		$43K Buy
+26,000
New +$41.1K ﹤0.01% 902

Other funds holding CPAH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wedbush Securities's CPAH Position: Q2 2020 in Review

Wedbush Securities sold out of Counterpath Corp (CPAH) in Q2 2020, closing a stake of 18,931 shares — an estimated $38K sold.

Wedbush Securities first reported a position in CPAH in Q1 2019 and held it in 5 quarters. The position peaked at $55K in Q4 2019. 9 funds tracked by Wall St. Rank hold CPAH as of Q2 2020.

  • Wedbush Securities reported no remaining Counterpath Corp position as of Q2 2020 after selling out during the quarter.
  • Wedbush Securities sold 18,931 Counterpath Corp shares in Q2 2020, an estimated $38K.
  • Wedbush Securities first reported a position in Counterpath Corp in Q1 2019 and held it in 5 quarters.
  • Wedbush Securities's Counterpath Corp position peaked at $55K in Q4 2019.
  • 9 funds tracked by Wall St. Rank held Counterpath Corp as of Q2 2020.

Based on Wedbush Securities's 13F filing for Q2 2020, filed 16 Jul 2020.